Experience of prolonged use of dienogest in the treatment of endometriosis

Background. Endometriosis is a chronic benign growth of endometrial-like tissues outside the uterine cavity. In the world, 6-10% of women of reproductive age are found, therefore, organ-preserving patience is the most preferred method of treatment. Progestins are the first-line drugs. Description. This article presents two clinical observations of patients with adenomyosis, long-term (over 6 years) use dienoguest (visanne) at a dose of 2 mg per day. Against the background of the drug, there is a marked improvement in health, a decrease in the level of pain syndrome, a decrease in the size of the uterus according to ultrasound. Conclusion. The presented clinical observations allow to recommend long-term therapy of adenomyosis with dienogest 2 mg (visanna drug), and confirm the high level of efficacy and safety of long-term therapy.

endometriosis, adenomyosis, progestin, dienogest